Cannabis Cuts Lung Cancer Tumor Growth In Half

After completing the first set of experiments, results showed the compound Delta-tetrahydrocannabinol [THC] inhibited EGF-induced growth and migration in epidermal growth factor receptor (EGFR) expressing non-small cell lung cancer cell lines. Lung cancers that over-express EGFR are usually are found highly aggressive and resistant to chemotherapy. The introduction of CB1 and CB2 is similar to endocannabinoids [naturally produced in the brain by everyone] activates these receptors. Researchers suggest that the THC activating these receptors may be used in a targeted fashion to treat lung cancer. Whereas the current leading treatment (chemotherapy) attacks every part of the body. Anju Preet, Ph.D., a researcher in the Division of Experimental Medicine, stated, “if used prudently, [THC] may offer a new road to therapy against lung cancer.” Can someone say prevention as well?

The above writing is summarized from materials provided by American Association for Cancer Research,

Comments are closed.

Hide me
Sign up below to join our Newsletter
Show me